Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer

被引：3
|
作者：
Zapatero, A. [1 ]
Guerrero, A. [2 ]
Maldonado, J. [3 ]
Alvarez, A. [4 ]
Gonzalez San Segundo, C. [4 ]
Cabeza Rodriguez, M. [4 ]
Macias, V. [5 ]
Pedro-Olive, A. [6 ]
Casas, F. [7 ]
Boladeras, A. [8 ]
Martin de Vidales, C. [1 ]
Vazquez de la Torre, M. [9 ]
Calvo, F. A. [4 ]
机构：
[1] Hosp Univ La Princesa, Madrid, Spain
[2] Hosp Son Dureta, Palma De Mallorca, Spain
[3] Hosp Valle De Hebron, Barcelona, Spain
[4] Hosp Univ Gregorio Maranon, Madrid, Spain
[5] Hosp Univ Salamanca, Hosp Gen Catalunya, Salamanca, Spain
[6] Clin Plato, Barcelona, Spain
[7] Hosp Clin Barcelona, Barcelona, Spain
[8] Inst Catala Oncol, Barcelona, Spain
[9] Hosp Meixoeiro, Vigo, Spain
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.06.018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL-02
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [21] Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States
    Falchook, Aaron D.
    Basak, Ramsankar
    Mohiuddin, Jahan J.
    Chen, Ronald C.
    JAMA ONCOLOGY, 2016, 2 (09) : 1236 - 1238
  • [22] Hypofractionated Radiation Therapy Versus Conventional Radiation Therapy in Patients With Intermediate- to High-Risk Localized Prostate Cancer
    Guo, W.
    Gao, X. S.
    Gu, X.
    Ma, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E236 - E237
  • [23] Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
  • [24] Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] LACK OF BENEFIT FOR THE ADDITION OF ANDROGEN DEPRIVATION THERAPY TO DOSE-ESCALATED RADIOTHERAPY IN THE TREATMENT OF INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
    Krauss, Daniel
    Kestin, Larry
    Ye, Hong
    Brabbins, Donald
    Ghilezan, Michel
    Gustafson, Gary
    Vicini, Frank
    Martinez, Alvaro
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 1064 - 1071
  • [26] Impact of Androgen Deprivation Therapy Associated to Conformal Radiotherapy in the Treatment of D'Amico Intermediate-/High-Risk Prostate Cancer in Older Patients
    Couderc, Anne-Laure
    Nicolas, Emanuel
    Boissier, Romain
    Boucekine, Mohammed
    Bastide, Cyrille
    Badinand, Delphine
    Rossi, Dominique
    Mugnier, Benedicte
    Villani, Patrick
    Karsenty, Gilles
    Cowen, Didier
    Lechevallier, Eric
    Muracciole, Xavier
    CANCERS, 2021, 13 (01) : 1 - 11
  • [27] Treatment timing in localized high-risk prostate cancer treated with radiation and androgen deprivation therapy
    Hasan, Shaakir
    Lazarev, Stanislav
    Gorovets, Daniel
    Garg, Madhur
    Press, Robert H.
    Choi, Isabelle
    Simone, Charles B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [28] Feasibility of androgen-deprivation and radiation therapy with docetaxel for localized high-risk prostate cancer
    Iwamoto, Hiroaki
    Izumi, Kouji
    Mizokami, Atsushi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (07) : 1324 - 1326
  • [29] Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients
    Katz, A.
    Kang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E250 - E250
  • [30] Utilization of a Novel Adaptive Dose Recalculation Tool in the Delivery of High-Dose Radiation for Intermediate- to High-Risk Prostate Cancer
    Edwards-Bennett, S. M.
    Herbert, A. J.
    Key, S. M.
    Andrews, S. F.
    Francke, P. M.
    Barton, R. A.
    Swist, J. D.
    Hodges, C. B.
    Walls, R. L.
    Root, W.
    Mahan, S. L.
    Mantz, C. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S877 - S878
12345